2022 Annual Report to the Nation: Overall cancer deaths continue to drop; some survival improvement in pancreatic cancer

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

To help accelerate research into new treatments for acute myeloid leukemia and myelodysplastic syndrome, Thermo Fisher Scientific Inc. is partnering with NCI on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial.

July 26, 2024

Vol.50 No.30

Conversation with The Cancer Letter

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

What can NCI accomplish in data science?

July 12, 2024

Vol.50 No.28

By Paul Goldberg

Judiciary News Analysis

Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care

The Supreme Court last week upended one of the underpinnings of administrative law by weakening the authority of federal health agencies to rely on technical expertise as they regulate medical products, issue coverage decisions, and respond to public health crises.

July 05, 2024

Vol.50 No.27

By Matthew Bin Han Ong

Conversation with The Cancer Letter

Georgetown’s Zachary Baron on the post-Chevron era: We need guardrails about when agency expertise should be cast aside

The Supreme Court struck down the Chevron doctrine, removing one of the foundational principles of administrative law and upending the way federal agencies rely on technical subject-matter expertise. What comes next?

July 05, 2024

Vol.50 No.27

By Matthew Bin Han Ong

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

Kate Choi grew up hearing conversations about skin cancer. Her grandparents had it, as did her cousins.

June 28, 2024

Vol.50 No.26

By McKenzie Prillaman

Clinical

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Cancer centers that continue to experience pandemic-induced shortages in staffing their clinical research enterprise may soon be able to rely on support from NCI’s Virtual Clinical Trials Office to open studies and accrue patients.

June 28, 2024

Vol.50 No.26

By Matthew Bin Han Ong

2022 Annual Report to the Nation: Overall cancer deaths continue to drop; some survival improvement in pancreatic cancer

YOU MAY BE INTERESTED IN

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care

Georgetown’s Zachary Baron on the post-Chevron era: We need guardrails about when agency expertise should be cast aside

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Renew today!

Subscriber content

Login

2022 Annual Report to the Nation: Overall cancer deaths continue to drop; some survival improvement in pancreatic cancer

YOU MAY BE INTERESTED IN

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”“All research now involves data science at some level.”

Supreme Court removes “Chevron deference,” threatening drug regulation, health coverage, delivery of cancer care

Georgetown’s Zachary Baron on the post-Chevron era: We need guardrails about when agency expertise should be cast aside

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forwardNCI’s Youth Enjoy Science (YES) program also invests in student scientists

NCI’s Virtual Clinical Trials Office fills the staffing shortages at cancer centers

Login

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists